Elicobacter pylori detected in atheroma plaque
Keywords:
Helicobacter pylori, atherosclerosis, atherorna plaque, autoimmunityAbstract
Introduction: In general, infection and chronic inflamination have been implied as etiologie agenls for atheroesclerosis and in particular eoronary illness (CI). Several studies have correlated the infeetion of Helicobacter pylori with CI, especially with virulent strains (lineage Cag A). Objective: Demonstrate the immunohistochemical presence of H. Pylori in atheroseletotic plaques obtained from endarterectomy of different vascular regions. Material and rnethods: 34 atherosclerotic plaques of different vascular arcas were studied, (25 men and 9 women). The tissues were fixed with 10% neutral buffered-formalin and decalcifying in formlc acid 5% was used when necessary. The tissue sections were included in paraffin, cut and colored with H&E and subjected to Immunohistochemistry (IHC) of H.Pylori. Briefly, tissues were deparaffinized and thermally treated with a citrate-based solution of antigenic retrieval (ImmunoDNA Retriever with Citrate, BIO SB, Santa Barbara, CA) using a water bath at 95°C for 1 hour. The IHC was conducted using a high sensiUvity Biotin- Streptavidin-HRP-DAB IHC system (ImmunoDetector HRP/DAB, BIO SB). The rnicroscopic observaUon evaluated the presence of mononuclear inflamrnatory celis and the identification of the bacteria in the wall or the vascular lumen. Results: Of the 34 cases studied 14 were positive, where one could identify the bacillus tu their different forms (41,17%) associated with chronic inflammation.
Downloads
References
Maseri A. Inflammation, atheroesclerosis and ischemic events: exploring the hidden side of the moon. N EnglJMed 1997:336:1014-1016.
Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atheroesclerosis: focus on CMV Lancet 1996; 349(suppl 1):s13-s17.
Saikku P Leinonen M Tenkanen L Linnanmaki E, Ekman MR, Marininen V, Mantairi M, Frick Mli, Atañen JK, Chronic Clamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992:116:273-278.
Kuo C-C, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demostration of Clamydia pneumoniae in atheroesclerosis lesions of the coronary arterles. J Infect DIs 1993:167:841-849.
Mendail MA, Goggia PM, Mollneaux N, Levy J, Toosy T, Slrachnan D. Lamm AJ; Northliedl TL. Relation of Helicobacter Pylori infection and coronary heart disease. Br Heart J 1994:71:437-439.
Sephen DH, Mainick M, Sorel G, Avinoam K, Henry Schwars, Shlomo P Aaron Mashiach, Zev S. Evaluation of carotid arterial plaques after endarterectomy for Helicobacter Pylori infection. Kaplan Medical Center. 1999; 1586-1857.
Cuffini, C. Guzmán L.A., Villegas, N. Et al. Isólation of Chlamydophila Neumoniae from atheromas of the carotid artery and their antibiotics susceptibility profile. Enferm. Infecc. Microbiol Clin 2006; 24(2): 81-5
Mobley, H.L.T., Island, M.D. & Hausinger, R.P Molecular Biology of Microbial Ureases, Microbio!. Rey. 59, 451-480(1995).
Pasceri y, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fideli G, Gasbarrini G, Maseri A. Association of virulent H. Pylori strains with ischemic heart disease. Circulation. 1998;97:1675- 1679.
Labigne, A. & de Reuse, H. Determinats of Helicobacter pylori pathogenicity. Infect. Agents Disease 5, 191-202(1996).
Atherton, J. C: et al. Mosaicism in vacuolating cytotoxin alle!es of Helicobacter Pylori. Association of apecific yac A types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270, 17771-17777 ( 1995).
Prevalence of Helicobacter Pyloni infection and its link to coronary risk factors in japanese patients with acute myocardial infarctlon. Kinjo K, Sato H, Sato H, Shiotani 1, Ohnishl Y et al. Circ J 2002 Sep:66(9):805-10.
Infection and Atherosclerosis. Emg mechanistic paradigms. Stephen E. Epstein, MD; Yi Fu Zhou, MD; Jianhui Zhu, MD, PhD. Circulation, 1999; 100: e20-e28.
Microbes, inflammation and at.herosclerosis: wlll old pathology lessons guide new therapies? Vercellotti CM. Trans Am Clin Climatol Assoc 2001; 112:215-22; Discussion 222-3.
Bedoya A, Garay J, Sanzon Fetal. Histopathology of Gastritis in Helicobacter Pylori-infect chlldren from populations at high and low gastric cancer risk. Hum Pathol 34:206-13,2003.
Las causa y la prevención del cáncer gástrico. Correa Pe!ayo. Conferencia Ruy Perez Tamayo. Quito, Ecuador. Octubre, 2003.
Detection of Helicobacter Pylori in Human Carotid Atherosclerotic Plaques. Sebastian Ameriso, MD; Esteban A. Fridman, MD; Ramón C.Leiguarda, MD: Gustavo E. Sevlever,MD. Stroke. 2001; 32:385-391.
Quin MT, Parthasarathy S, Fong L, Steinberg D Oxidatively modified low density liproteins: a potential role in the recruiment and retention of monocyte/ macrophages during atherogenesis. Proc Nati Acad Sci USA 1987; 84:2.995-2.998.
Panthasarathy S. Quinn MT, Schewenke DC, Carew TE, steinberg D Oxidative modification of beta-very density lipoprotein: potential role in monocyte recruiment and foam cdl fonmation. Arteriosclerosis 1989; 9:398.
Maas M, Krause E, Kruger S. EngeiR Bartels C Direct demostration of Clamydia pneumoniae in atherosclerotic lesions and in circulating blood cells (resumen 101). Yverdon-Les-Brains, Suiza: Fourth !nternational Simposium of Modern Concepts in Endocarditis anci Cardiovascular Infections, Mayo de 1997 21. 50th Congress of the American College of Cardiology. Marzo de 2001. Andrew D. Michaels, Ariana Del Negro, Augustus O. Grant, Bramah N. Singh, Christopher P Cannon, Eva Stein, F'ahim Jafary, Gerald V. Naccarelli, John Gottdeiner, Jorge Plutzky, Ken Dauterman, Luis Gruberg, Marvin Moser, Murray Epstein, Peter R. Kowey, Phillip Sager, Raphael Rosenhek, Stephen Epstein, Warren J. Manning, William.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.
